Medtronic plc Unrealized Gain (Loss) on Investments
Medtronic plc (MDT) reported Unrealized Gain (Loss) on Investments of $1.00 million for the 6-month period ending 2022-10-28, per its 10-Q filed 2023-11-30.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnInvestments · last filed 2023-11-30
- 2022-10-28: Unrealized Gain (Loss) on Investments 6 month $1.00M.
| Period end | Unrealized Gain (Loss) on Investments 6 month |
|---|---|
| 2022-10-28 | $1.00M 10-Q · filed 2023-11-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B |